Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias
Phase 1/Phase 2
15 Years
40 Years
15 Years
40 Years
Not Enrolling
Both
Chemotherapy Induced Oral Mucositis
Both
Chemotherapy Induced Oral Mucositis
Trial Information
Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias
Inclusion Criteria:
- patient under chemotherapy
- for a hematologic malignancy
- the hematologist permits the trial on the patient
- agreement of patient for participating in the trial
Exclusion Criteria:
- presence pf ANY oral lesion at the beginning of the trial
- loss of follow up
- use of digoxin and cyclosporine
- patient death
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
lower grade of mucositis
Outcome Description:
grade of mucositis due to WHO criteria
Outcome Time Frame:
3 weeks
Safety Issue:
No
Principal Investigator
Pegah Mosannen Mozafari, assistant professor
Investigator Role:
Study Director
Investigator Affiliation:
Mashhad University of Medical Sciences
Authority:
Iran: Ministry of Health
Study ID:
89470
NCT ID:
NCT01732393
Start Date:
January 2010
Completion Date:
January 2012
Related Keywords:
- Chemotherapy Induced Oral Mucositis
- Quercetin
- Chemotherapy
- Mucositis
- Hematologic Malignancies
- Stomatitis
- Mucositis
Name | Location |
|---|
